Strengthening Global ATMP Logistics: How Cryoport Systems’ Netherlands Facility Supports Temperature-Controlled Supply Chains
The success of Advanced Therapy Medicinal Products (ATMPs) depends on more than just scientific breakthroughs, it requires a highly controlled, risk-mitigated supply chain that ensures product integrity from research through commercialization. With cell and gene therapies moving across multiple clinical sites, manufacturing facilities, and regulatory jurisdictions, developers need a logistics partner that can support seamless, temperature-controlled supply chain management at a global scale.
Cryoport Systems’ Global Logistics Center in Amsterdam, Netherlands, serves as a central hub for biopharmaceutical companies needing robust, temperature-controlled and compliant cryogenic, dry ice, and refrigerated (2-8°C) shipping solutions designed specifically for sensitive materials. With its strategic location and integrated cold chain capabilities, this facility plays a crucial role in ensuring that high-value, time- and temperature-sensitive therapies move efficiently across Europe and beyond.
Managing ATMP Logistics in a Complex Regulatory Environment
ATMP developers and contract manufacturers face significant challenges in transporting highly sensitive cellular materials across international borders. These challenges include:
- Maintaining precise temperature control during transit (oftentimes with industry leading hold times) to prevent cellular degradation or loss of viability.
- Navigating customs clearance and trade regulations, particularly for cryopreserved, patient-specific materials that must adhere to strict import/export requirements.
- Ensuring near real-time tracking and 24/7/365 visibility and monitoring.
- Coordinating specialized transportation that can handle the unique demands of cell and gene therapies.
Without a robust, integrated supply chain infrastructure, ATMP developers risk delays, compliance issues, and potential loss of irreplaceable therapeutic materials.
A Global Logistics Center in Amsterdam
Cryoport Systems’ Netherlands facility is strategically positioned to address these challenges, providing:
- Industry-leading temperature-controlled packaging and shipping solutions for cryogenic, dry ice, and refrigerated shipments.
- State-of-the-art informatics and data monitoring technology for consistent tracking, ensuring complete visibility and control over shipments with full chain of custody and Chain of Compliance®.
- Specialized transportation services, including Cryoshuttle® local pickup and delivery service, to enable local and regional movement of sensitive materials.
- Expert customs clearance support to navigate regulatory requirements and reduce transit delays.
By combining cutting-edge shipping systems, regulatory expertise, and robust tracking technologies that monitor more than just location, including near real-time reporting on internal and external temperature, tilt, shock, and more, Cryoport Systems enables ATMP developers to transport materials with confidence, compliance, and efficiency.
A Strategic Location for Global ATMP Distribution
Amsterdam has long been a critical logistics gateway for Europe, with well-established infrastructure supporting pharmaceutical, biopharmaceutical, and life sciences supply chains. Its central location, major international airport, and advanced trade networks make it an ideal location for biopharma companies needing reliable access to European and global markets.
The Cryoport Systems Global Logistics Center in Amsterdam strengthens this ecosystem, providing a dedicated, GMP-compliant facility that supports the safe and efficient movement of ATMPs between research sites, manufacturing facilities, and clinical trial locations worldwide.
With ATMP development continuing to expand globally, supply chain reliability is more critical than ever. The Netherlands facility provides integrated, temperature-controlled logistics solutions that help developers overcome regulatory and logistical challenges, ensuring that therapies reach patients without compromise.
For ATMP sponsors, contract manufacturers, and clinical teams looking to optimize their global supply chain strategy, Cryoport Systems offers the infrastructure, expertise, and risk-mitigation solutions needed to protect the integrity of life-saving therapies at every stage.